AnalyzeDirect Bothwell KD, Shaurova T, Merzianu M, Suresh A, Kuriakose MA, Johnson CS, Hershberger PA, Seshadri M. Impact of short-term 1,25-dihydroxyvitamin D3 on the chemopreventive efficacy of erlotinib against oral cancer. Cancer Prev Res (Phila). June 22015.
Publication Date
June 2015
How Analyze was Used
“Following MR image acquisition, raw image sets were transferred to a processing workstation and converted into Analyze™ format (AnalyzeDirect, version 7.0; Overland Park, KS). A region of interest (ROI) was traced around the entire tumor and saved as an object map.”
Keywords
4-Nitroquinoline-1-oxide
Animals
Carcinogenesis
Carcinogens
Carcinoma, Sqamous Cell Of Head And Neck
Chemoprevention
Disease Models, Animal
Disease Progression
Erlotinib
Magnetic Resonance Imaging (MRI)
Mice
Receptor, Epidermal Growth Factor
Treatment Outcome
Vitamin D
Author Affiliation(s)
Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, US. (KDB, TS, CSJ)
Department of Pathology, Roswell Park Cancer Institute, Buffalo, NY, US. (MM)
Integrated Head and Neck Oncology Research Program, Mazumdar Shaw Centre for Translational Research, Bangalore, India. (AS)
Head and Neck Oncology, Mazumdar Shaw Medical Centre, Bangalore, India. (MAK)
Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, US. (PAH)
Pharmacology and Therapeutics, Head and Neck Surgery, Roswell Park Cancer Institute, Buffalo, NY, US. (MS)
ID# 2938
Tags: 4-Nitroquinoline-1-oxide, Animal Disease Models, Animals, Carcinogenesis, Carcinogens, Carcinoma_Sqamous Cell of Head and Neck, Chemoprevention, Disease Progression, Epidermal Growth Factor Receptor, Erlotinib, Magnetic Resonance Imaging (MRI), Mice, Treatment Outcome, Vitamin D